SGL5213 is a potent, oral active and low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor, with IC50 values of 29 nM and 20 nM for hSGLT1 and hSGLT2, respectively. SGL5213 has potential to treat type 2 diabetes treatment[1].
Molecular Weight:
669.85
CAS Number:
[1240305-17-2]
Formula:
C37H55N3O8
Target:
SGLT
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
